CerFlux
Business Services · Alabama, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
215 Richard Arrington Jr Blvd N Ste 101,...Website
www.cerflux.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CerFlux
CerFlux specializes in personalized medicine technology aimed at matching cancer treatments to individual tumors, ensuring effective treatment from the outset. Their innovative approach, known as the Personalized Oncology Efficacy Test (POET), allows for the simultaneous screening of multiple therapy agents on biopsy tissue, identifying the most effective treatment options within a week. The company addresses the critical need for personalized cancer treatment, reducing the risk of ineffective therapies and associated costs. CerFlux serves patients, healthcare providers, payors, and pharmaceutical companies in the fight against cancer.Explore more
CerFlux Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CerFlux your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CerFlux has new funding data
Website visits: Recent activity has been detected on your website
Check if CerFlux has recently received funding, and reach out quickly before it becomes old news!
Check out if CerFlux is spiking on competitors!
Click to see if CerFlux had a recent Job posting/layoffs
Product Launch: Get notified when CerFlux launches new products
CerFlux, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CerFlux recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at CerFlux
Recommended Actions
Reach out to Masked Content who joined CerFlux as Masked Content
Find 2 more new buyers
Compare Similar Companies to CerFlux
Compare insights from companies similar to CerFlux, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CerFlux is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CerFlux is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CerFlux.
CerFlux financials insights
Gather financial insights about CerFlux, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$1M
CerFlux Tech Stack
A closer look at the technologies used by CerFlux
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Project
Award, Spending/Investment
Funding
Funding
CerFlux News & Media
CerFlux raises $1 million in seed capital
A Birmingham-based health tech company will use seed capital in its quest to find the best treatments and cure for cancer.CerFlux receives grant from Breast Cancer Research Foundation of Alabama
A Birmingham company will purchase equipment to process breast cancer tumor specimens, thanks to the BCRFA.CERFLUX Announces Breast Cancer Research Foundation of Alabama Award
Grant will support advanced imaging technology at the CerFlux lab. (PRWeb December 18, 2020) Read the full story at https://www.prweb.com/releases/cerflux_announces_breast_cancer_research_foundation_of_alabama_award/prweb17621183.htmCERFLUX Announces National Cancer Institute Award
Grant will support development of low-cost and rapid Personalized Oncology Efficacy Test (POET) for Pancreatic Cancer (PRWeb September 14, 2020) Read the full story at https://www.prweb.com/releases/cerflux_announces_national_cancer_institute_award/prweb17389948.htm
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CerFlux
Sign Up For FreeTo access detailed company insights
CerFlux specializes in personalized medicine technology aimed at matching cancer treatments to individual tumors, ensuring effective treatment from the outset. Their innovative approach, known as the Personalized Oncology Efficacy Test (POET), allows for the simultaneous screening of multiple therapy agents on biopsy tissue, identifying the most ef... Read More
